Veeva Systems Inc.

Equities

VEEV

US9224751084

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2024-05-28 pm EDT			5-day change	1st Jan Change
203.1 ^USD	-0.39%		-2.94%	+5.49%

May. 17	Troy Announces Selection of Veeva Vault QualityDocs and Veeva Vault Training to Simplify Its Compliance, Content Management, and Data Processes	CI
May. 16	Veeva Systems Inc. Introduces Vault Basics for Biotechs	CI

Veeva Systems Inc. Provides Revenue Guidance for the Third Quarter of 2023

November 08, 2022 at 06:13 am EST

Veeva Systems Inc. provided revenue guidance for the third quarter of 2023. For the period, the company expects total revenue of $545-547 million, subscription revenue of ~$439 million and services revenue of $106-108 million.

Latest news about Veeva Systems Inc.

Troy Announces Selection of Veeva Vault QualityDocs and Veeva Vault Training to Simplify Its Compliance, Content Management, and Data Processes	May. 16	CI
Veeva Systems Inc. Introduces Vault Basics for Biotechs	May. 16	CI
Veeva Systems Insider Sold Shares Worth $681,116, According to a Recent SEC Filing	Apr. 24	MT
Veeva Systems Insider Sold Shares Worth $746,297, According to a Recent SEC Filing	Apr. 16	MT
Tech Down on Flight From Risk -- Tech Roundup	Apr. 02	DJ
News Highlights : Top Company News of the Day - Tuesday at 5 PM ET	Apr. 02	DJ
Sector Update: Tech Stocks Slump Late Afternoon	Apr. 02	MT
Sector Update: Tech	Apr. 02	MT
News Highlights : Top Company News of the Day - Tuesday at 3 PM ET	Apr. 02	DJ
News Highlights : Top Company News of the Day - Tuesday at 1 PM ET	Apr. 02	DJ
Veeva Systems Shares Fall After Chief Financial Officer Brent Bowman Steps Down	Apr. 02	MT
Sector Update: Tech Stocks Decline Pre-Bell Tuesday	Apr. 02	MT
Veeva Systems Chief Financial Officer Steps Down	Apr. 02	MT
Veeva Systems Inc. Announces CFO Changes	Apr. 01	CI
Veeva Systems Inc. Announces Executive Changes	Apr. 01	CI
Veeva Systems Inc. Reiterates Earnings Guidance for the First Quarter Ending April 30, 2024 and for the Fiscal Year Ending January 31, 2025	Apr. 01	CI
Add a little SaaS to your life	Mar. 14
Not a care in the world	Mar. 13
JPMorgan Raises Veeva Systems Price Target to $222 From $183, Maintains Neutral Rating	Mar. 13	MT
ANALYST RECOMMENDATIONS : Broadcom, Tesla, Walmart, Entain, Virgin Money UK	Mar. 13
Another disappointment	Mar. 12
Morgan Stanley Raises Price Target on Veeva Systems to $210 From $160 Amid Multiple Expansion in Large-Capitalization Software; Underweight Kept	Mar. 12	MT
ANALYST RECOMMENDATIONS : Coinbase, Dollar General, Target, Veeva, Capita...	Mar. 12
Transcript : Veeva Systems Inc. Presents at Morgan Stanley?s Technology, Media & Telecom Conference 2024, Mar-06-2024 09:30 AM	Mar. 06
KeyBanc Raises Price Target on Veeva Systems to $250 From $232, Keeps Overweight Rating	Mar. 05	MT

Chart Veeva Systems Inc.

Duration

Period

More charts

Company Profile

Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Companyâs three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-30 - Q1 2025 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Veeva Systems Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

203.1 USD

Average target price

242 USD

Spread / Average Target

+19.14%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

	1st Jan change	Capi.
VEEVA SYSTEMS INC.	+5.49%	32.95B
PRO MEDICUS LIMITED	+20.16%	7.87B
SECTRA AB	+33.25%	4.35B
EVOLENT HEALTH, INC.	-30.09%	2.67B
OMNICELL, INC.	-13.90%	1.5B
VERADIGM INC.	-16.59%	1.27B
LUNIT INC.	-35.41%	1.16B
SIMULATIONS PLUS, INC.	+11.17%	996M
B-SOFT CO.,LTD.	-39.85%	859M
SURGICAL SCIENCE SWEDEN AB	-21.32%	679M

Medical Software & Technology Services